Inactivation of nuclear factor κB by MIP-based drug combinations augments cell death of breast cancer cells

BACKGROUND: Drug combination therapy to treat cancer is a strategic approach to increase successful treatment rate. Optimizing combination regimens is vital to increase therapeutic efficacy with minimal side effects. MATERIALS AND METHODS: In the present study, we evaluated the in vitro cytotoxicity...

Descripción completa

Detalles Bibliográficos
Autores principales: Subramaniam, Menaga, Liew, Su Ki, In, Lionel LA, Awang, Khalijah, Ahmed, Niyaz, Nagoor, Noor Hasima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935191/
https://www.ncbi.nlm.nih.gov/pubmed/29750018
http://dx.doi.org/10.2147/DDDT.S141925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935191/
https://www.ncbi.nlm.nih.gov/pubmed/29750018
http://dx.doi.org/10.2147/DDDT.S141925

Ejemplares similares